Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report

Senores Pharmaceuticals filed its FY26 BRSR for the year ending Mar'26. Standalone turnover reached INR 10,609 lakhs, alongside a net worth of INR 74,990

Senores Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report

Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 10:38 pm

Senores Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report Senores Pharmaceuticals filed its FY26 BRSR for the year ending Mar'26. Standalone turnover reached INR 10,609 lakhs, alongside a net worth of INR 74,990 lakhs. Exports contributed 43.95% to total turnover. Highlighting strong operational compliance, the company reported zero regulatory penalties, product recalls, or data breaches during the year. Environmentally, Senores maintained its Zero Liquid Discharge status at the Mehsana plant and recorded total non-renewable energy consumption of 22.50 Tera Joules. Management confirmed full adherence to environmental and labor regulations with no pending stakeholder complaints.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements